Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Consultant360 spoke with Karen Hansen, MD, whose study suggests that parathyroid hormone may be an independent predictor of fractures, vascular events, and mortality in some patients with chronic kidney...
Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
